Merck & Co. Inc. (MRK) Tops Q1 EPS by 8c; Guides FY11 EPS

April 29, 2011 7:02 AM EDT
Merck & Co. Inc. (NYSE: MRK) reported Q1 EPS of $0.92, $0.08 better than the analyst estimate of $0.84. Revenue for the quarter came in at $11.58 billion versus the consensus estimate of $11.37 billion.

Merck & Co. Inc. sees FY2011 EPS of $3.66-$3.76, versus the consensus of $3.69.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings